Blood biomarkers predict conversion from cognitively stable to mild cognitive impairment or Alzheimer's disease in Down syndrome at 16-month follow-up in ABC-DS.

Saved in:
Bibliographic Details
Title: Blood biomarkers predict conversion from cognitively stable to mild cognitive impairment or Alzheimer's disease in Down syndrome at 16-month follow-up in ABC-DS.
Authors: Zhang F; Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, Texas, USA.; Department of Family Medicine, University of North Texas Health Science Center, Fort Worth, Texas, USA., Petersen M; Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, Texas, USA.; Department of Family Medicine, University of North Texas Health Science Center, Fort Worth, Texas, USA., Mapstone M; Department of Neurology, University of California, Irvine, California, USA., Hall J; Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, Texas, USA.; Department of Family Medicine, University of North Texas Health Science Center, Fort Worth, Texas, USA., Handen B; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Christian B; Department of Medical Physics and Psychiatry, University of Wisconsin Madison, Madison, Wisconsin, USA., Head E; Department of Pathology & Laboratory Medicine, Department of Neurology, University of California, Irvine, California, USA., Rosas HD; Departments of Neurology and Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA., Lai F; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA., Lee JH; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, New York, USA.; Gertrude H. Sergievsky Center, Columbia University Irving Medical Center, New York, New York, USA.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.; Department of Neurology, Neurological Institute, Columbia University Irving Medical Center, New York, New York, USA., Krinsky-McHale SJ; Department of Psychology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York, USA., Schmitt FA; Department of Neurology, University of Kentucky, Lexington, Kentucky, USA., Harp J; Department of Neurology, University of Kentucky, Lexington, Kentucky, USA., Hom C; Department of Psychiatry & Human Behavior, University of California, Irvine, California, USA., Lott IT; Department of Pediatrics, University of California, Irvine, California, USA., Hartley S; Department of Human Development and Family Studies, University of Wisconsin-Madison, Madison, Wisconsin, USA., Zaman S; Department of Psychiatry, University of Cambridge, Cambridge, Cambridgeshire, UK., Ances BM; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA., Ptomey L; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA., Burns JM; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA., Cohen AD; Department of Radiology, University of Pittsburgh, Pennsylvania, Pittsburgh, USA., Brickman AM; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA., Bryant SEO; Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, Texas, USA.; Department of Family Medicine, University of North Texas Health Science Center, Fort Worth, Texas, USA.
Corporate Authors: Alzheimer's Biomarkers Consortium‐Down Syndrome (ABC‐DS) Investigators*
Source: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2026 Jul; Vol. 22 (7), pp. e71659.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1552-5279
DOI:10.1002/alz.71659